We are live on ! Find out more
GEHC icon

GE HealthCare

1,311 hedge funds and large institutions have $28.3B invested in GE HealthCare in 2025 Q2 according to their latest regulatory filings, with 122 funds opening new positions, 490 increasing their positions, 462 reducing their positions, and 162 closing their positions.

New
Increased
Maintained
Reduced
Closed

6% more repeat investments, than reductions

Existing positions increased: 490 | Existing positions reduced: 462

4% more call options, than puts

Call options by funds: $296M | Put options by funds: $285M

0.27% less ownership

Funds ownership: 83.59%83.32% (-0.27%)

4% less funds holding

Funds holding: 1,3671,311 (-56)

8% less capital invested

Capital invested by funds: $30.8B → $28.3B (-$2.56B)

22% less funds holding in top 10

Funds holding in top 10: 97 (-2)

25% less first-time investments, than exits

New positions opened: 122 | Existing positions closed: 162

Holders
1,311
Holders Change
-56
Holders Change %
-4.1%
% of All Funds
17.26%
Holding in Top 10
7
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-22.22%
% of All Funds
0.09%
New
122
Increased
490
Reduced
462
Closed
162
Calls
$296M
Puts
$285M
Net Calls
+$10.9M
Net Calls Change
-$193M
Name Holding Trade Value Shares
Change
Change in
Stake
II
226
IFM Investors
Australia
$6.93M +$480K +6,899 +8%
Mackenzie Financial
227
Mackenzie Financial
Ontario, Canada
$6.8M +$432K +6,211 +7%
TAMH
228
Taikang Asset Management (HK)
Hong Kong
$6.76M +$6.36M +91,323 New
CWM
229
CIBC World Markets
New York
$6.68M +$2.44M +35,093 +64%
AB
230
Amalgamated Bank
New York
$6.57M -$254K -3,646 -4%
Wellington Management Group
231
Wellington Management Group
Massachusetts
$6.45M +$220K +3,155 +4%
WP
232
Woodline Partners
California
$6.24M +$2.09M +30,092 +56%
JFG
233
Jefferies Financial Group
New York
$6.22M -$5.87M -84,262 -50%
UIM
234
USS Investment Management
United Kingdom
$6.22M +$186K +2,675 +3%
Pacer Advisors
235
Pacer Advisors
Pennsylvania
$6.21M +$2.62M +37,677 +82%
DnB Asset Management
236
DnB Asset Management
Norway
$6.17M +$362K +5,207 +7%
EI
237
Ecofi Investissements
France
$6.16M -$2.45M -35,200 -37%
Macquarie Group
238
Macquarie Group
Australia
$6.09M -$107M -1,537,296 -95%
WTC
239
WhitTier Trust Company
Nevada
$6.08M +$155K +2,226 +3%
BC
240
Broadwater Capital
Massachusetts
$6.07M +$417K +5,992 +7,307%
AF
241
Allworth Financial
California
$6.06M +$240K +3,442 +4%
SLAM
242
Swiss Life Asset Management
$5.99M +$1.22M +17,572 +28%
FWC
243
First Washington Corp
Washington
$5.99M
Verition Fund Management
244
Verition Fund Management
Connecticut
$5.93M +$1.29M +18,501 +30%
NCM
245
Northside Capital Management
Oregon
$5.9M +$5.54M +79,655 New
Cetera Investment Advisers
246
Cetera Investment Advisers
Illinois
$5.9M -$35.8K -514 -0.6%
AAM
247
Azzad Asset Management
Virginia
$5.88M +$57K +819 +1%
Mariner
248
Mariner
Kansas
$5.84M -$174K -2,497 -3%
CI
249
Cooper Investors
Australia
$5.83M -$9.55M -137,204 -64%
BCI
250
Brinker Capital Investments
Pennsylvania
$5.78M +$624K +8,959 +13%

GEHC Hedge Fund Activity: Q2 2025 in Review

1,311 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in GE HealthCare (GEHC) for Q2 2025, worth a combined $28.3B — down 8.3% from $30.8B a quarter earlier.

Sellers outnumbered buyers: 162 funds closed out of GEHC and 122 opened new positions — a net loss of 40 holders — while 462 trimmed existing stakes and 490 added.

The largest buyer was Dodge & Cox, adding an estimated $486M. The largest seller was Capital Research Global Investors, cutting an estimated $2.17B.

  • 1,311 institutional investors held GE HealthCare (GEHC) as of Q2 2025, down from 1,367 in Q1 2025.
  • Funds reported $28.3B of GE HealthCare stock for Q2 2025, down 8.3% quarter-over-quarter.
  • 122 funds opened new GE HealthCare positions in Q2 2025 and 162 closed out, a net change of -40 holders.
  • The largest GE HealthCare buyer in Q2 2025 was Dodge & Cox, an estimated $486M added.
  • The largest GE HealthCare seller in Q2 2025 was Capital Research Global Investors, an estimated $2.17B sold.

Based on aggregated 13F filings for Q2 2025.